New World alphavirus protein interactomes from a therapeutic perspective

Antiviral Res. 2019 Mar:163:125-139. doi: 10.1016/j.antiviral.2019.01.015. Epub 2019 Jan 26.

Abstract

The New World alphaviruses, Venezuelan, eastern and western equine encephalitis viruses (VEEV, EEEV, and WEEV), are important human pathogens due to their ability to cause varying levels of morbidity and mortality in humans. There is also concern about VEEV and EEEV being used as bioweapons. Currently, a FDA-approved antiviral is lacking for New World alphaviruses. In this review, the function of each viral protein is discussed with an emphasis on how these functions can be targeted by therapeutics. Both direct acting antivirals as well as inhibitors that impact host protein interactions with viral proteins are described. Non-structural protein 3 (nsP3), capsid, and E2 proteins have garnered attention in recent years, whereas little is known regarding host protein interactions of the other viral proteins and is an important avenue for future study.

Keywords: Alphavirus; Antivirals; Capsid; Host processes; nsP2; nsP3.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Alphavirus / drug effects*
  • Alphavirus / physiology
  • Alphavirus Infections / drug therapy*
  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Cell Line
  • Clinical Trials as Topic
  • Host Microbial Interactions / drug effects
  • Humans
  • Mice
  • Viral Proteins / chemistry*
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Viral Proteins